Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 64,000 shares at $41.01 ($2.6M) on 2026-04-15, disclosed to the SEC on 2026-04-15.
Scheduled sale ($2.6M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.01 | 56,815 | $2.3M | 88.6% |
| 2 | $41.75 | 7,165 | $299K | 11.4% |
| 3 | $42.66 | 20 | $853 | 0.0% |
| Total | $41.09 avg | 64,000 | $2.6M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |
| TVTX | SELL | 2026-02-03 | $3.2M | — | Filing → |